Lazard Asset Management’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,136
| Closed | -$36K | – | 2455 |
|
|
2025
Q1 | $36K | Sell |
4,136
-68,031
| -94% | -$592K | ﹤0.01% | 2050 |
|
|
2024
Q4 | $989K | Buy |
72,167
+7,614
| +12% | +$104K | ﹤0.01% | 1155 |
|
|
2024
Q3 | $1.77M | Buy |
64,553
+26,904
| +71% | +$736K | ﹤0.01% | 900 |
|
|
2024
Q2 | $920K | Buy |
37,649
+16,506
| +78% | +$403K | ﹤0.01% | 991 |
|
|
2024
Q1 | $449K | Buy |
21,143
+9,036
| +75% | +$192K | ﹤0.01% | 1079 |
|
|
2023
Q4 | $231K | Buy |
12,107
+164
| +1% | +$3.13K | ﹤0.01% | 1337 |
|
|
2023
Q3 | $191K | Buy |
11,943
+7,268
| +155% | +$116K | ﹤0.01% | 1401 |
|
|
2023
Q2 | $107K | Buy |
4,675
+1,925
| +70% | +$44.1K | ﹤0.01% | 1557 |
|
|
2023
Q1 | $63K | Buy |
2,750
+1,514
| +122% | +$34.7K | ﹤0.01% | 1720 |
|
|
2022
Q4 | $17K | Hold |
1,236
| – | – | ﹤0.01% | 2153 |
|
|
2022
Q3 | $23K | Buy |
+1,236
| New | +$23K | ﹤0.01% | 2068 |
|
|
2021
Q3 | – | Sell |
-1,774
| Closed | -$54K | – | 2243 |
|
|
2021
Q2 | $54K | Buy |
+1,774
| New | +$54K | ﹤0.01% | 1567 |
|
|
2019
Q4 | – | Sell |
-521
| Closed | -$14K | – | 1614 |
|
|
2019
Q3 | $14K | Buy |
+521
| New | +$14K | ﹤0.01% | 1185 |
|